Stocks Listing
EVO

Evotec SE

Share
EVO
$8.59 3.37%Last Updated Sep 23 2022 07:56 PM
1D Low / 1D High
Low:$8.56
High:$8.79
1D
3.37%
5D
13.23 %
30D
27.08 %
BulletPurple
Market Cap
$3,000,092,160
4.02 %
3 B
BulletBlue
Volume 1D
23,093
-
23.1 K
BulletOrange
Circulating Supply
349,254,035 EVO
349.3 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Evotec SE operates as a drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as neuronal diseases, diabetes and complications of diabetes, pain, inflammation, oncology, infectious diseases, respiratory diseases, fibrosis, rare diseases, and women's health. It has collaboration agreements with Bayer AG; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Celgene; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Opened
NMS
NASDAQ Stock Exchange
USA
Closes in
4 hours, 43 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0